The top executive of pharmaceutical giant Pfizer said it was still not clear whether those who received the company’s vaccine would be able to pass the coronavirus to others, just a day after the UK became the first to approve the inoculation.
While Pfizer CEO Albert Bourla has said he expects the vaccine deployment to be swift after getting the green light from US health officials, following in Britain’s footsteps, he noted that it remains to be seen whether vaccine recipients can still carry and pass the virus.
“Even though I had protection, can I still pass it on to other people?” NBC’s Lester Holt asked in an interview Thursday night, causing surprise reply from Bourla:
I think this is something that needs to be looked at. We are not sure at this time.
World-renowned microbiologist Sucharit Bhakdi, MD, made an appearance Wednesday night on Fox News’ “Ingraham Angle” to alert the world of a hastily produced COVID-19 vaccine.
Last month, Pfizer announced that its vaccine – developed alongside German company BioNTech – was found to be over 90% effective in immunizing trial participants, getting the green light from British health authorities on Wednesday to begin. distribution for widespread use.
Pfizer has sought emergency approval from the US Food and Drug Administration (FDA), but the agency has been more reluctant to pass the vaccination, with leading infectious disease expert Anthony Fauci saying than his British counterparts “Really rushed this approval” while praising the FDA “very attentive” authorization process.
While both pharmaceutical companies support the efficacy of their vaccine, an inability to stop transmission from virus carriers could mean the inoculation does not meet the high expectations expressed by some officials in the US and UK. .
#Pfizer #CEO #vaccine #stop #transmission #Covid19 #companys #vaccine #approved #evaluated #Dateway